Andrea Stadlbauer, Patricia Fiedler, Simon Tuemmler, Michael Gruber, Christof Schmid, Timo F Seyfried
{"title":"Is surgical smoke a relevant contamination for salvaged autologous blood? A pilot study.","authors":"Andrea Stadlbauer, Patricia Fiedler, Simon Tuemmler, Michael Gruber, Christof Schmid, Timo F Seyfried","doi":"10.1111/vox.70040","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Electrocautery-related surgical smoke removed together with the intraoperative blood collection through suction devices might be a potential hazard. The degree of contamination of the autologous blood despite cell recovery and its possible harm to the patient remain subjects of research.</p><p><strong>Materials and methods: </strong>Two types of laboratory experiments and one clinical study were conducted. Initially, toluene was added to banked erythrocytes mixed with fresh frozen plasma. This reconstituted blood was processed using the autotransfusion device XTRA, and the elimination of toluene was calculated via gas chromatography (GC). In a second experiment, slices of pigskin were cut with electrocautery while dropping reconstituted blood onto the cauterization point. The resulting smoke and the blood were sucked into a cell salvage reservoir and washed with the XTRA. Samples from the reservoir and the product were analysed by GC. The average elimination rate was calculated. In a clinical study, blood samples were collected from the reservoir of the cell saver system during cardiac surgery and analysed likewise.</p><p><strong>Results: </strong>The autotransfusion device removed 92% of toluene from the processed blood. Other unidentified contaminants showed an elimination rate above 97.9%.</p><p><strong>Conclusion: </strong>Cell salvage devices significantly reduce the amount of contaminants in wound blood. Nevertheless, despite this highly effective detoxication, the remaining contaminants may still pose a potential risk to the patient.</p>","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vox Sanguinis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/vox.70040","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and objectives: Electrocautery-related surgical smoke removed together with the intraoperative blood collection through suction devices might be a potential hazard. The degree of contamination of the autologous blood despite cell recovery and its possible harm to the patient remain subjects of research.
Materials and methods: Two types of laboratory experiments and one clinical study were conducted. Initially, toluene was added to banked erythrocytes mixed with fresh frozen plasma. This reconstituted blood was processed using the autotransfusion device XTRA, and the elimination of toluene was calculated via gas chromatography (GC). In a second experiment, slices of pigskin were cut with electrocautery while dropping reconstituted blood onto the cauterization point. The resulting smoke and the blood were sucked into a cell salvage reservoir and washed with the XTRA. Samples from the reservoir and the product were analysed by GC. The average elimination rate was calculated. In a clinical study, blood samples were collected from the reservoir of the cell saver system during cardiac surgery and analysed likewise.
Results: The autotransfusion device removed 92% of toluene from the processed blood. Other unidentified contaminants showed an elimination rate above 97.9%.
Conclusion: Cell salvage devices significantly reduce the amount of contaminants in wound blood. Nevertheless, despite this highly effective detoxication, the remaining contaminants may still pose a potential risk to the patient.
期刊介绍:
Vox Sanguinis reports on important, novel developments in transfusion medicine. Original papers, reviews and international fora are published on all aspects of blood transfusion and tissue transplantation, comprising five main sections:
1) Transfusion - Transmitted Disease and its Prevention:
Identification and epidemiology of infectious agents transmissible by blood;
Bacterial contamination of blood components;
Donor recruitment and selection methods;
Pathogen inactivation.
2) Blood Component Collection and Production:
Blood collection methods and devices (including apheresis);
Plasma fractionation techniques and plasma derivatives;
Preparation of labile blood components;
Inventory management;
Hematopoietic progenitor cell collection and storage;
Collection and storage of tissues;
Quality management and good manufacturing practice;
Automation and information technology.
3) Transfusion Medicine and New Therapies:
Transfusion thresholds and audits;
Haemovigilance;
Clinical trials regarding appropriate haemotherapy;
Non-infectious adverse affects of transfusion;
Therapeutic apheresis;
Support of transplant patients;
Gene therapy and immunotherapy.
4) Immunohaematology and Immunogenetics:
Autoimmunity in haematology;
Alloimmunity of blood;
Pre-transfusion testing;
Immunodiagnostics;
Immunobiology;
Complement in immunohaematology;
Blood typing reagents;
Genetic markers of blood cells and serum proteins: polymorphisms and function;
Genetic markers and disease;
Parentage testing and forensic immunohaematology.
5) Cellular Therapy:
Cell-based therapies;
Stem cell sources;
Stem cell processing and storage;
Stem cell products;
Stem cell plasticity;
Regenerative medicine with cells;
Cellular immunotherapy;
Molecular therapy;
Gene therapy.